ATG16L1 and Cowden disease: The discovery by Hampe et al. of ATG16L1 T300A as a CD risk factor was followed later that year by a second study that confirmed this variant’s association with CD and further demonstrated that the loss of ATG16L1 in vitro hampered anti-bacterial autophagy (termed “xenophagy”) of Salmonella enterica subsp.